Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - grass pollen extract 100 ir; allergen extracts 300 ir (grass pollen) - sublingual tablet - active: grass pollen extract 100 ir excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose active: allergen extracts 300 ir (grass pollen) excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose - treatment of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive cutaneous test and/or a positive titre of the specific ige to the grass pollen.

Estados Unidos - inglês - NLM (National Library of Medicine)

nelco laboratories, inc. - paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Estados Unidos - inglês - NLM (National Library of Medicine)

nelco laboratories, inc. - paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Estados Unidos - inglês - NLM (National Library of Medicine)

nelco laboratories, inc. - paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Estados Unidos - inglês - NLM (National Library of Medicine)

nelco laboratories, inc. - paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Estados Unidos - inglês - NLM (National Library of Medicine)

nelco laboratories, inc. - paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Estados Unidos - inglês - NLM (National Library of Medicine)

nelco laboratories, inc. - paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

stallergenes s.a. - grass pollen allergen extract - tablet sublingual - 100/300

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - alternaria alternata, quantity: 0.5 ml (equivalent: alternaria alternata, qty 10 mg/ml); phoma herbarum, quantity: 0.5 ml (equivalent: phoma herbarum, qty 10 mg/ml); cochliobolus heterostrophus, quantity: 0.25 ml (equivalent: cochliobolus heterostrophus, qty 5 mg/ml); aspergillus fumigatus, quantity: 0.1 ml (equivalent: aspergillus fumigatus, qty 3 mg/ml); aspergillus terreus, quantity: 0.1 ml (equivalent: aspergillus terreus, qty 3 mg/ml); aspergillus nidulans, quantity: 0.1 ml (equivalent: aspergillus nid - extract, liquid - excipient ingredients: glycerol; sodium chloride; sodium bicarbonate; water for injections - indicated use of allergenic extracts is for the diagnosis and treatment (hypo-sensitization therapy) of patients who experience allergic symptoms.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - hair, quantity: 1 ml/ml (equivalent: hair, qty 100 mg/ml) - extract, liquid - excipient ingredients: glycerol; sodium chloride; sodium bicarbonate; water for injections - indicated use of allergenic extracts is for the diagnosis and treatment (hypo-sensitization therapy) of patients who experience allergic symptoms.